Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: A meta-regression analysis

Journal of Clinical Sleep Medicine

Volumn 10, Issue 5, 2014, Pages 475-489

  Nadeem, Rashid ^a   Singh, Mukesh ^b   Nida, Mahwish ^c   Waheed, Irfan ^a   Khan, Adnan ^a   Ahmed, Saeed ^d   Naseem, Jawed ^e   Champeau, Daniel ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b James A Lovell Federal Health Care Center   (United States)

^c Rematul Lil Alameen Institute of Cardiology   (Pakistan)

^d NEW YORK UNIVERSITY   (United States)

^e UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Atherosclerosis; Cholesterol; Dyslipidemia; Obstructive sleep apnea; Sleep disordered breathing

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; SENSITIVITY ANALYSIS; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; BLOOD; COMPLICATION; DYSLIPIDEMIAS; METABOLISM; REGRESSION ANALYSIS;

ADULT; CHOLESTEROL; DYSLIPIDEMIAS; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; REGRESSION ANALYSIS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; TRIGLYCERIDES;

EID: 84901200475     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.3690     Document Type: Article

References (51)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5. (Pubitemid 23115702)
2. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465-84.
3. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283:1829-36. (Pubitemid 30207619)
4. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84. (Pubitemid 30262394)
5. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. (Pubitemid 32095247)
6. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159-65. (Pubitemid 34765451)
7. Imadojemu VA, Gleeson K, Gray KS, Sinoway LI, Leuenberger UA. Obstructive sleep apnea during sleep is associated with peripheral vasoconstriction. Am J Respir Crit Care Med 2002;165:61-6. (Pubitemid 34053358)
8. Sajkov D, Wang T, Saunders NA, Bune AJ, McEvoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:152-8. (Pubitemid 34084449)
9. Amin RS, Kimball TR, Bean JA, et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:1395-9. (Pubitemid 34522943)
10. Rebuffè-Scrive M, Mårin P, Björntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 1991;15:791-5.
11. Barceló A, Barbé F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004;117:118-21 (Pubitemid 38953732)
12. Barceló A, Barbé F, de la Peña M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008;63:946-50.
13. Bhushan B, Guleria R, Misra A, Pandey RM, Luthra K, Vikram NK. Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians. Nutr Metab Cardiovasc Dis 2009;19:184-9.
14. Can M, Açikgöz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-7. (Pubitemid 43289839)
15. Cofta S, Wysocka E, Michalak S, Piorunek T, Batura-Gabryel H, Torlinski L. Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males. Eur J Med Res 2009;14 Suppl 4:49-52.
16. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41. (Pubitemid 38647933)
17. Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010;208:490-5
18. Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest 2003;26:493-8. (Pubitemid 36998695)
19. Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J 2011;38:1089-97
20. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006;5:22.
21. Guill S, Hargens T, Nickols-Richardson S, et al. Early evidence of increased risk for metabolic syndrome in young men with latent obstructive sleep apnea. Metab Syndr Relat Disord 2010;8:33-8
22. Iesato K, Tatsumi K, Saibara T, et al. Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J 2007;71:1293-8. (Pubitemid 47195349)
23. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118:580-6
24. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007;131:1387-92. (Pubitemid 46762343)
25. Lin QC, Zhang XB, Chen GP, Huang DY, Din HB, Tang AZ. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 2012;16:571-8.
26. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007;175:190-5. (Pubitemid 46115091)
27. Monneret D, Borel JC, Pepin JL, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res 2010;20:127-33
28. Ozol D, Turkay C, Kasapoglu B, Karamanli H, Yildirim Z. Relationship between components of metabolic syndrome and polysomnographic findings in obstructive sleep apnea. Metab Syndr Relat Disord 2011;9:13-8
29. Panaree B, Chantana M, Wasana S, Chairat N. Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath 2011;15:649-56.
30. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 2007;101:1696-701 (Pubitemid 46947878)
31. Salord N, Mayos M, Miralda R, Perez A. Respiratory sleep disturbances in patients undergoing gastric bypass surgery and their relation to metabolic syndrome. Obes Surg 2009;19:74-9
32. Sánchez-de-la-Torre M, Pierola J, Vidal C, et al. Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea Sleep Breath 2011;15:403-8.
33. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing Sleep Med 2007;8:12-7. (Pubitemid 46044133)
34. Tan KC, Chow WS, Lam JC, et al. MS HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377-82 (Pubitemid 43049723)
35. Trakada G, Steiropoulos P, Nena E, et al. Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome Sleep Breath 2009;13:349-55
36. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Method 2005;5:13.
37. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine - How to practice and teach EBM, 2nd ed. Oxford: Churchill Livingstone, 2000:173-75.
38. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
39. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
40. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
41. Emberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R. N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol 2007;49:311-9.
42. Cleland JGF, McMurray JJV, Kjekshus J, et al.; CORONA Study Group. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 2009;54:1850-9.
43. Adedayo AM, Olafiranye O, Smith D, et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 2014;18:13-8.
44. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Lévy P. Semin Immunopathol 2009;31:113-25.
45. Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013;9:1003-12
46. Klein RL, Ascencao JL, Mironova M, Huang Y, Lopes-Virella MF. Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells. Metabolism 2001;50:99-106 (Pubitemid 32058556)
47. Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006;27:121-7 (Pubitemid 43092675)
48. Quan SF, Budhiraja R, Clarke DP, et al. Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med 2013;9:989-93.
49. Fava C, Dorigoni S, Dalle Vedove F, et al. Effect of continuous positive airway pressure (CPAP) on blood pressure in patients with obstructive sleep apnea/hypopnea. A systematic review and meta-analysis. Chest 2013 Sep 26. [Epub ahead of print].
50. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 2012;35:617-25B.
51. Mota PC, Drummond M, Winck JC, Santos AC, Almeida J, Marques JA. APAP impact on metabolic syndrome in obstructive sleep apnea patients. Sleep Breath 2011;15:665-72.